Active	Status	Sponsor type	Region	Phase	Filter
12 Active 5 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Everett, Sandra L
NEOPAX, NCT05969496: Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma with Inferior Vena Cava Tumor Thrombus	Recruiting	2	17	US	Axitinib, Inlyta, Pembrolizumab, Keytruda	University of Colorado, Denver, Cancer League of Colorado	Renal Cancer, Kidney Cancer, Renal Cell Carcinoma, Inferior Vena Cava Thrombosis	11/26	11/29
NCT05515978: Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients	Recruiting	1	200	US	Metformin, Glucophage, Riomet, Glumetza, Lifestyle Modification	University of Colorado, Denver	Prostate Cancer	10/35	11/36
Weiner, Asher
NCT03894631: Effect of Intra-subject Phaco/Trabectome vs. Phaco/Kahook Dual Blade on Intraocular Pressure	Completed	N/A	80	US	KDB/Phacoemulsification, Trabectome/Phacoemulsification	State University of New York at Buffalo	Glaucoma	11/23	11/23
B350vsCP250, NCT04542616: Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma	Completed	N/A	80	US	Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation	State University of New York at Buffalo	Glaucoma	07/24	07/24
DECLARE, NCT05924477: Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial	Recruiting	N/A	226	Canada, US	Sulcus tube placement, Anterior chamber (AC) tube placement	University of Pennsylvania, National Eye Institute (NEI), University of California, San Francisco, Stanford University	Glaucoma	12/26	12/27
Michalovic, Sharon
NCT04564378: Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure	Completed	N/A	43	US	This is an observational study. There is no therapeutic intervention.	State University of New York at Buffalo	Fuchs Dystrophy	04/23	09/23
B350vsCP250, NCT04542616: Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma	Completed	N/A	80	US	Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation	State University of New York at Buffalo	Glaucoma	07/24	07/24
VENICE, NCT05280366: STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma	Active, not recruiting	N/A	150	US, RoW	Streamline Surgical System, iStent Inject W	New World Medical, Inc.	Open Angle Glaucoma	06/26	06/26
TARGET-DERM, NCT03661866: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC	Recruiting	N/A	15000	Europe, Canada, US		Target PharmaSolutions, Inc.	Atopic Dermatitis, Alopecia Areata, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Chronic Spontaneous Urticaria	12/50	12/50
Patel, Sagita
NCT04564378: Association Between Fuchs' Endothelial Corneal Dystrophy Severity and Estrogen Exposure	Completed	N/A	43	US	This is an observational study. There is no therapeutic intervention.	State University of New York at Buffalo	Fuchs Dystrophy	04/23	09/23
Sieminski, Sandra F
NCT05523622: Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices	Recruiting	N/A	300	US	Tono-Vera tonometer, Goldman Applanation Tonometry	State University of New York at Buffalo, Reichert, Inc.	Glaucoma	12/24	12/24
VENICE, NCT05280366: STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma	Active, not recruiting	N/A	150	US, RoW	Streamline Surgical System, iStent Inject W	New World Medical, Inc.	Open Angle Glaucoma	06/26	06/26